Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Upstream Bio, Inc. | Director, 10%+ Owner | Common Stock | 4.55M | Oct 15, 2024 | Indirect | ||
Upstream Bio, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 17.1K | Oct 10, 2024 | Direct | ||
Upstream Bio, Inc. | Director, 10%+ Owner | Series A redeemable convertible preferred stock | 0 | Oct 15, 2024 | Indirect | ||
Upstream Bio, Inc. | Director, 10%+ Owner | Series B redeemable convertible preferred stock | 0 | Oct 15, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
UPB | Upstream Bio, Inc. | Oct 15, 2024 | 8 | $14M | 4 | Oct 17, 2024 | Director, 10%+ Owner |
UPB | Upstream Bio, Inc. | Oct 10, 2024 | 1 | $0 | 4 | Oct 15, 2024 | Director |
UPB | Upstream Bio, Inc. | Oct 10, 2024 | 0 | $0 | 3 | Oct 10, 2024 | Director, 10%+ Owner |